Mayne Pharma Inc: Drug Recall
Recall #D-1152-2022 · 06/09/2022
Class II: Risk
Recall Details
- Recall Number
- D-1152-2022
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Mayne Pharma Inc
- Status
- Terminated
- Date Initiated
- 06/09/2022
- Location
- Greenville, NC, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1440 cartons
Reason for Recall
Defective Delivery System: Out of specification for release liner removal force results at the 3-month CRT stability timepoint.
Product Description
Clonidine Transdermal System, USP 0.3 mg/day, 4 Patches (NDC 51862-455-01) per Carton (51862-455-04), Rx only, Manufactured for: Mayne Pharma Greenville, NC 27834
Distribution Pattern
Nationwide in the US Market
Other Recalls by Mayne Pharma Inc
- Class II: Risk 01/14/2022
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.